{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:57Z","timestamp":1707525657982},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,3]]},"DOI":"10.7759\/cureus.51607","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T01:30:46Z","timestamp":1704331846000},"source":"Crossref","is-referenced-by-count":0,"title":["Two Cases With Type 1 Diabetes Treated With Insulin Pump Therapy Using a Telemedicine Approach During the COVID-19 Pandemic"],"prefix":"10.7759","author":[{"given":"Haremaru","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13306","article-title":"Japanese clinical practice guideline for diabetes 2019","volume":"11","author":"Araki E","year":"2020","unstructured":"Araki E, Goto A, Kondo T, et al.. Japanese clinical practice guideline for diabetes 2019. J Diabetes Investig. 2020, 11:1020-76. 10.1111\/jdi.13306","journal-title":"J Diabetes Investig"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dci21-0043","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt RI","year":"2021","unstructured":"Holt RI, DeVries JH, Hess-Fischl A, et al.. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021, 44:2589-625. 10.2337\/dci21-0043","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203913","article-title":"Open-source automated insulin delivery in type 1 diabetes","volume":"387","author":"Burnside MJ","year":"2022","unstructured":"Burnside MJ, Lewis DM, Crocket HR, et al.. Open-source automated insulin delivery in type 1 diabetes. N Engl J Med. 2022, 387:869-81. 10.1056\/NEJMoa2203913","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-022-00853-6","article-title":"Psychosocial aspects of continuous subcutaneous insulin infusion in children with type 1 diabetes in Egypt; a limited resources country perspective","volume":"14","author":"El Samahy MH","year":"2022","unstructured":"El Samahy MH, Salah NY, Abdeen MS, Falastin BR. Psychosocial aspects of continuous subcutaneous insulin infusion in children with type 1 diabetes in Egypt; a limited resources country perspective. Diabetol Metab Syndr. 2022, 14:82. 10.1186\/s13098-022-00853-6","journal-title":"Diabetol Metab Syndr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16245124","article-title":"Perceptions of residents among rural communities with medical group practice in Japan","volume":"16","author":"Manabe T","year":"2019","unstructured":"Manabe T, Sawada T, Kojo T, Iguchi S, Haruyama S, Maeda T, Kotani K. Perceptions of residents among rural communities with medical group practice in Japan. Int J Environ Res Public Health. 2019, 16:5124. 10.3390\/ijerph16245124","journal-title":"Int J Environ Res Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1297\/cpe.17.39","article-title":"Changes in glycemic control and quality of life in pediatric type 1 diabetics with continuous subcutaneous insulin infusion of insulin aspart following multiple daily injection therapy","volume":"17","author":"Kawamura T","year":"2008","unstructured":"Kawamura T, Urakami T, Sugihara S, Kim HS, Mochizuki M, Amamiya S. Changes in glycemic control and quality of life in pediatric type 1 diabetics with continuous subcutaneous insulin infusion of insulin aspart following multiple daily injection therapy. Clin Pediatr Endocrinol. 2008, 17:39-47. 10.1297\/cpe.17.39","journal-title":"Clin Pediatr Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"Battelino T","year":"2023","unstructured":"Battelino T, Alexander CM, Amiel SA, et al.. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023, 11:42-57. 10.1016\/S2213-8587(22)00319-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ21-0540","article-title":"Clinical feasibility of remote intermittently scanned continuous glucose monitoring in coronavirus disease 2019 patients with and without diabetes during dexamethasone therapy","volume":"69","author":"Shimizu N","year":"2022","unstructured":"Shimizu N, Hayashi A, Ito S, et al.. Clinical feasibility of remote intermittently scanned continuous glucose monitoring in coronavirus disease 2019 patients with and without diabetes during dexamethasone therapy. Endocr J. 2022, 69:597-604. 10.1507\/endocrj.EJ21-0540","journal-title":"Endocr J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s41745-023-00363-y","article-title":"Reducing the cost of diabetes care with telemedicine, smartphone, and home monitoring","volume":"103","author":"Kesavadev J","year":"2023","unstructured":"Kesavadev J, Mohan V. Reducing the cost of diabetes care with telemedicine, smartphone, and home monitoring. J Indian Inst Sci. 2023, 103:231-42. 10.1007\/s41745-023-00363-y","journal-title":"J Indian Inst Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2021.06.013","article-title":"COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring","volume":"15","author":"Salabelle C","year":"2021","unstructured":"Salabelle C, Ly Sall K, Eroukhmanoff J, et al.. COVID-19 pandemic lockdown in young people with type 1 diabetes: Positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring. Prim Care Diabetes. 2021, 15:884-6. 10.1016\/j.pcd.2021.06.013","journal-title":"Prim Care Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2196\/42607","article-title":"Glycemic control, renal progression, and use of telemedicine phone consultations among Japanese patients with type 2 diabetes mellitus during the COVID-19 pandemic: retrospective cohort study","volume":"8","author":"Sankoda A","year":"2023","unstructured":"Sankoda A, Nagae Y, Waki K, et al.. Glycemic control, renal progression, and use of telemedicine phone consultations among Japanese patients with type 2 diabetes mellitus during the COVID-19 pandemic: retrospective cohort study. JMIR Diabetes. 2023, 8:e42607. 10.2196\/42607","journal-title":"JMIR Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino T","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, et al.. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019, 42:1593-603. 10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S007","article-title":"7. Diabetes technology: standards of medical care in diabetes-2022","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee. 7. Diabetes technology: standards of medical care in diabetes-2022. Diabetes Care. 2022, 45:S97-112. 10.2337\/dc22-S007","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817697330","article-title":"The percentage of continuous subcutaneous insulin infusion usage among adult type 1 diabetes mellitus patients in Japan: a cross-sectional study at national hospital organization hospitals","volume":"11","author":"Murata T","year":"2017","unstructured":"Murata T, Aoki Y, Kato Y, et al.. The percentage of continuous subcutaneous insulin infusion usage among adult type 1 diabetes mellitus patients in Japan: a cross-sectional study at national hospital organization hospitals. J Diabetes Sci Technol. 2017, 11:1055-6. 10.1177\/1932296817697330","journal-title":"J Diabetes Sci Technol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.endinu.2018.04.003","article-title":"Clinical value of flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion","volume":"65","author":"Moreno-Fernandez J","year":"2018","unstructured":"Moreno-Fernandez J, Pazos-Couselo M, Gonz\u00e1lez-Rodriguez M, Rozas P, Delgado M, Aguirre M, Garcia-Lopez JM. Clinical value of flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion. Endocrinol Diabetes Nutr. 2018, 65:556-63. 10.1016\/j.endinu.2018.04.003","journal-title":"Endocrinol Diabetes Nutr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.324","article-title":"RT-CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: systemic review and meta-analysis","volume":"5","author":"William J","year":"2022","unstructured":"William J, McCluskey J, Gleeson N. RT-CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: systemic review and meta-analysis. Endocrinol Diabetes Metab. 2022, 5:e00324. 10.1002\/edm2.324","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820950753","article-title":"Successful initiation of hybrid closed-loop system using virtual pump training program in a teenager with type 1 diabetes previously treated with multiple daily injections","volume":"15","author":"Petrovski G","year":"2021","unstructured":"Petrovski G, Campbell J, Almajali D, Al Khalaf F, Hussain K. Successful initiation of hybrid closed-loop system using virtual pump training program in a teenager with type 1 diabetes previously treated with multiple daily injections. J Diabetes Sci Technol. 2021, 15:1394-8. 10.1177\/1932296820950753","journal-title":"J Diabetes Sci Technol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02051-w","article-title":"Early and sustained increase in time in range 1\u00a0year after initiation of hybrid close loop therapy via telemedicine in type 1 diabetes patients","volume":"60","author":"G\u00f3mez AM","year":"2023","unstructured":"G\u00f3mez AM, Henao D, Parra D, et al.. Early and sustained increase in time in range 1\u00a0year after initiation of hybrid close loop therapy via telemedicine in type 1 diabetes patients. Acta Diabetol. 2023, 60:943-9. 10.1007\/s00592-023-02051-w","journal-title":"Acta Diabetol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3513-z","article-title":"Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group","volume":"58","author":"Heinemann L","year":"2015","unstructured":"Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia. 2015, 58:862-70. 10.1007\/s00125-015-3513-z","journal-title":"Diabetologia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00996-7","article-title":"Application of telemedicine in diabetes care: the time is now","volume":"12","author":"Aberer F","year":"2021","unstructured":"Aberer F, Hochfellner DA, Mader JK. Application of telemedicine in diabetes care: the time is now. Diabetes Ther. 2021, 12:629-39. 10.1007\/s13300-020-00996-7","journal-title":"Diabetes Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/217544-two-cases-with-type-1-diabetes-treated-with-insulin-pump-therapy-using-a-telemedicine-approach-during-the-covid-19-pandemic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:41Z","timestamp":1707509561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/217544-two-cases-with-type-1-diabetes-treated-with-insulin-pump-therapy-using-a-telemedicine-approach-during-the-covid-19-pandemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.51607","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,3]]}}}